Issue Date: February 8, 2010
Tree Bark Inspires Vaccine Adjuvants
Weak antigens used in antitumor and antiviral vaccines often require an adjuvant, a substance that helps stimulate enough of an immune response to make the vaccine effective. But few such adjuvants are currently available. David Y. Gin and colleagues at Memorial Sloan-Kettering Cancer Center, in New York City, are reporting some new compounds that could extend the family of vaccine adjuvants (J. Am. Chem. Soc., DOI: . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society